Analytical testing, QC

(Image: Getty/Murat Göçmen)

State of the Industry: What readers have to say

By Melissa Fassbender

Outsourcing-Pharma recently conducted a second ‘state of the industry’ survey to gauge views about the current state of the global pharmaceutical outsourcing market and the evolving relationships of those involved.

(Image: Getty/peshkov)

BIO 2018

Celltrion gets into outsourcing with Bio CDMO launch

By Melissa Fassbender

Celltrion has launched Bio CDMO, its new contract development and manufacturing business and part of the company's "open innovation strategy" to expand its drug pipeline portfolio.

(Image: WuXi AppTec Co., Ltd.)

WuXi AppTec IPO tops $353m

By Melissa Fassbender

The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

(Image: Getty/eaglesky)

CRO market to reach $44.4bn by 2021

By Melissa Fassbender

The global contract research organization (CRO) market is forecasted to grow 12% year-on-year through 2021 – led by IQVIA with 12.4% of the market share.

(Image: Getty/oatwa)

RxCelerate acquires specialist bioanalytical CRO

By Melissa Fassbender

UK-headquartered RxCelerate has acquired the specialist bioanalytical contract research organization Total Scientific – increasing its staff to 37 following its expansion stateside in November 2017.

(Image: Getty/denisik11)

Letter to the editor

Sizing up: Does CRO consolidation leave space for smaller firms?

By Melissa Fassbender

A continued need for specialized services and expertise will keep smaller firms in business – though many have forecasted the “death of small- to mid-sized CROs” as the industry continues to consolidate, say experts.

(Image: Getty/Arindam Ghosh)

Microbial CMO Wacker buys Dutch biotech plant

By Melissa Fassbender

Wacker Chemie has acquired SynCo Bio’s site for manufacturing biopharmaceuticals, live microbial products, and vaccines, as well as its associated business, including more than 100 employees.

(Image: Getty/Image Source)

Charles River bolsters global biologics business

By Melissa Fassbender

Charles River has made several expansions across the globe, including a new, 73,000 square-foot facility in Wayne, PA, which doubles its laboratory footprint in the state.

(Image: Getty/martince2)

SCOPE 2018

A CRO monopoly? Sponsors frustrated with lack of options

By Melissa Fassbender

With fewer global mid-sized contract research organizations (CRO) through consolidation, some stakeholders are expressing concern that the industry could become a monopoly – “we may be getting there,” one expert said.

Follow us

Product Innovations

dPCR Case Study

dPCR Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...